FormDSignal

Akebia Therapeutics, Inc. (AKBA)

1 Item 5.02 filing since 2026-10-14 · 1 with an open seat · roles: Other. Nasdaq. Pharmaceutical Preparations. State: MA.

ScoreFiledEventRolePersonSeatSummary
502026-10-14DepartureOthersubscribersOpenAkebia Therapeutics, Inc. (AKBA): Other Nicholas Grund resigned

Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works